Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma

被引:1
|
作者
Ebinc, Senar [1 ]
Oruc, Zeynep [1 ]
Kalkan, Ziya [1 ]
Karhan, Ogur [1 ]
Urakci, Zuhat [1 ]
Kucukoner, Mehmet [1 ]
Kaplan, Muhammet Ali [1 ]
Abdurrahman, Isikdogan [1 ]
机构
[1] Dicle Univ, Fac Med, Dept Internal Med, Div Med Oncol, Diyarbakir, Turkiye
关键词
Inflammation indices; malignant pleural mesothelioma; prognostic nutritional index; prognostic score; SURVIVAL; CANCER; RATIO; LYMPHOCYTE; PARAMETERS;
D O I
10.5606/tgkdc.dergisi.2023.23365
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: In this study, we aimed to investigate the prognostic factors of malignant pleural mesothelioma and the prognostic value of inflammation indices in malignant pleural mesothelioma. Methods: Between January 2002 and December 2019, a total of 132 patients (74 males, 58 females; mean age: 55 years; range, 31 to 79 years) diagnosed with malignant pleural mesothelioma were retrospectively analyzed. Patients' demographic data and laboratory results were recorded. The prognostic value of the following five inflammation indices was evaluated: neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, advanced lung cancer inflammation index, C-reactive protein/albumin ratio, and prognostic nutritional index. Results: Of all patients, 81% (n=107) were aged 65 or older and 61.4% (n=81) had an epithelioid histology. Of 12 variables examined in the multivariate analysis for their relationship with survival, age >= 65 years, non-epithelioid subtype, and prognostic nutritional index <40 were found to be poor prognostic factors. Based on the score constructed from these factors, the good prognostic group (score 0-1) had a median overall survival of 21 months and a one-year survival rate of 77.9%, while the poor prognostic group (score 2-3) had a median overall survival of nine months and a one-year survival rate of 29.7%. Conclusion: Our study results indicate that age >= 65 years, prognostic nutritional index <40, and non-epithelioid histological subtype are poor prognostic factors of malignant pleural mesothelioma.
引用
收藏
页码:105 / 115
页数:11
相关论文
共 50 条
  • [31] Immunohistochemistry as Prognostic Markers for Malignant Pleural Mesothelioma
    Otsuki, Taiichiro
    Maehashi, Nobuko
    Kataoka, Yuki
    Terada, Takayuki
    Kuribayashi, Kozo
    Hirabayashi, Masataka
    Ieki, Ryuji
    Nakano, Takashi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S505 - S505
  • [32] Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma
    Bille, Andrea
    Krug, Lee M.
    Woo, Kaitlin M.
    Rusch, Valerie W.
    Zauderer, Marjorie G.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : 249 - 255
  • [33] Lume trial: searching for survival prognostic factors in malignant pleural mesothelioma
    Proto, C.
    Lo Russo, G.
    Macerelli, M.
    Vitali, M.
    Agustoni, F.
    Platania, M.
    Zilembo, N.
    Ganzinelli, M.
    Tiseo, M.
    Pasello, G.
    Gallucci, R.
    Cona, M. S.
    Botta, L.
    Trama, A.
    de Braud, F.
    Garassino, M. C.
    Signorelli, D.
    ANNALS OF ONCOLOGY, 2015, 26 : 76 - 76
  • [34] Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factors
    Yan, Tristan D.
    Boyer, Michael
    Tin, Mo Mo
    Wong, Daniel
    Kennedy, Catherine
    McLean, Jocelyn
    Bannon, Paul G.
    McCaughan, Brian C.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (03): : 619 - 624
  • [35] Is Laboratory Prognostic Index a Valuable Prognostic Index for Malignant Pleural Mesothelioma?
    Tuylu, T. Basoglu
    Demircan, N. C.
    Arikan, R.
    Telli, T. Akin
    Alan, O.
    Ercelep, O.
    Bozkurtlar, E.
    Kocakaya, D.
    Kaya, S.
    Babacan, N.
    Lacin, T.
    Dane, F.
    Ahiskali, R.
    Batirel, H.
    Yumuk, P. F.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S763 - S763
  • [36] Prognostic factors in malignant pleural mesothelioma (MPM): A mono-institutional evaluation of Bologna Malignant Pleural Mesothelioma Group.
    Adua, Daniela
    Sperandi, Francesca
    Castellucci, Paolo
    Melotti, Barbara
    Giaquinta, Stefania
    Fanti, Stefano
    Pinto, Carmine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma (MPM)
    Bille, Andrea
    Zauderer, Marjorie
    Woo, Kaitlin
    Rusch, Valerie W.
    Krug, Lee M.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S404 - S404
  • [38] DIAGNOSIS AND PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA - A RETROSPECTIVE ANALYSIS OF 65 PATIENTS
    TAMMILEHTO, L
    MAASILTA, P
    KOSTIAINEN, S
    APPELQVIST, P
    HOLSTI, LR
    MATTSON, K
    RESPIRATION, 1992, 59 (03) : 129 - 135
  • [39] Prognostic Factors In Malignant Pleural Mesothelioma: A Retrospective Study Of Sixty Turkish Patients
    Koyuncu, A.
    Koksal, D.
    Ozmen, O.
    Demirag, F.
    Bayiz, H.
    Aydogdu, K.
    Berkoglu, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [40] Histologic Assessment and Prognostic Factors of Malignant Pleural Mesothelioma Treated With Extrapleural Pneumonectomy
    Arrossi, Andrea V.
    Lin, E.
    Rice, David
    Moran, Cesar A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (05) : 754 - 764